Detalhe da pesquisa
1.
Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis.
Nat Immunol
; 20(10): 1404, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409923
2.
The immune cell landscape in kidneys of patients with lupus nephritis.
Nat Immunol
; 20(7): 902-914, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209404
3.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
N Engl J Med
; 387(10): 894-904, 2022 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36069871
4.
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
N Engl J Med
; 387(4): 321-331, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939578
5.
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II).
Lancet
; 401(10381): 1011-1019, 2023 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848919
6.
Multi-cell type gene coexpression network analysis reveals coordinated interferon response and cross-cell type correlations in systemic lupus erythematosus.
Genome Res
; 31(4): 659-676, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674349
7.
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Ann Rheum Dis
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754981
8.
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.
Rheumatology (Oxford)
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530774
9.
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
Ann Rheum Dis
; 82(7): 927-936, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085289
10.
Epidemiology and outcomes of emergency department visits in systemic lupus erythematosus: Insights from the nationwide emergency department sample (NEDS).
Lupus
; 32(14): 1646-1655, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961765
11.
What Bedside Skills Could the Modern Rheumatologist Possess? Part I. The Basics.
J Clin Rheumatol
; 2023 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37553898
12.
What Bedside Skills Could the Modern Rheumatologist Possess? Part II. "Certain Technical Procedures".
J Clin Rheumatol
; 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37983677
13.
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials.
Ann Rheum Dis
; 81(7): 962-969, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580976
14.
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials.
Ann Rheum Dis
; 81(7): 951-961, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338035
15.
Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus.
Ann Rheum Dis
; 2022 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798534
16.
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Ann Rheum Dis
; 81(3): 370-378, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34911705
17.
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership.
Rheumatology (Oxford)
; 61(11): 4335-4343, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35212719
18.
An ACVR1R375P pathogenic variant in two families with mild fibrodysplasia ossificans progressiva.
Am J Med Genet A
; 188(3): 806-817, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34854557
19.
Regarding Arthroscopy: Can Orthopedists and Rheumatologists Be Friends?
J Clin Rheumatol
; 28(3): 177-181, 2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325902
20.
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).
Mod Rheumatol
; 32(1): 59-67, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274687